Welcome to the 2021 LUPUS CORA Meeting Program Scheduling

The meeting will officially run on Central European Summer Time (CEST), GMT +2

To convert the meeting times to your local time Click Here

 

Displaying One Session

No Topic Needed

Session Type
Live e-Poster Discussion
Date
Fri, 08.10.2021
Session Time
13:15 - 14:15
Room
Hall 3
Chair(s)
  • Johanna Mucke (Germany)
Session Description
Topics covered: PERSONALISED MEDICINE IN SLE, NEW THERAPIES AND THERAPEUTIC TARGETS IN SLE and SMALL MOLECULES AND INHIBITORS

TELEMEDICINE FOR TIGHT MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: VIDEO-VISITING SHOWED GOOD SPECIFICITY BUT LOW SENSITIVITY IN TREATMENT DECISIONS

Presenter
  • ELISABETTA CHESSA (Italy)
Lecture Time
13:15 - 13:19

EFFICACY OF ANIFROLUMAB FOR PATIENTS WITH PEDIATRIC-ONSET AND ADULT-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN 2 PHASE 3 TRIALS

Presenter
  • Edward M. Vital (United Kingdom)
Lecture Time
13:19 - 13:23

TAPERING BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE CENTER EXPERIENCE

Presenter
  • Micaela Fredi (Italy)
Lecture Time
13:23 - 13:27

ADAPTIVE DESIGN OF A PHASE 2B STUDY ASSESSING THE SAFETY AND EFFICACY OF THE IL-2 MUTEIN EFAVALEUKIN ALFA IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Presenter
  • Elaine Karis (United States of America)
Lecture Time
13:27 - 13:31

LEFLUNOMIDE: A SAFE AND EFFECTIVE ALTERNATIVE IN SYSTEMIC LUPUS ERYTHEMATOSUS

Presenter
  • Irene Carrión-Barberà (Spain)
Lecture Time
13:35 - 13:39

DISCOVERY OF BMS-986256, A SMALL MOLECULE DUAL ANTAGONIST OF THE TOLL-LIKE RECEPTORS 7 AND 8 (TLR7/8) ADVANCED TO CLINICAL TRIALS FOR THE TREATMENT OF LUPUS

Presenter
  • Alaric J. Dyckman (United States of America)
Lecture Time
13:39 - 13:43

Live Q&A

Lecture Time
13:43 - 14:19